Credit:
Dr. Dourson is the President of Toxicology Excellence for Risk Assessment (TERA), a nonprofit corporation dedicated to the best use of toxicity data in risk assessment. TERA develops partnerships among government, industry and other interested groups to address risk assessments of high visibility, such as formaldehyde, perchlorate, chloroform, and soluble nickel, and cooperative ventures such as the Voluntary Children’s Chemical Exposure Program (VCCEP), the International Toxicity Estimates for Risk (ITER) database (available at the National Library of Medicine’s ToxNet), and the Alliance for Risk Assessment (ARA). Before founding TERA in 1995, Dr. Dourson held leadership roles in the U.S. Environmental Protection Agency as chair of US EPA's Reference Dose (RfD) Work Group, charter member of the US EPA's Risk Assessment Forum and chief of the group that helped create the Integrated Risk Information System (IRIS).
Dr. Dourson received his Ph.D. in Toxicology from the University of Cincinnati. He is a Diplomate of the American Board of Toxicology and a Fellow of the Academy of Toxicological Sciences and Society for Risk Analysis.
Dr. Dourson has served on or chaired numerous expert panels, including peer review panels for US EPA IRIS assessments, US EPA’s Risk Assessment Forum, TERA’s International Toxicity Estimates for Risk (ITER) independent peer reviews and consultations, FDA’s Science Board Subcommittee on Toxicology, the NSF International’s Health Advisory Board, and SOT’s harmonization of cancer and non-cancer risk assessment. He served as Secretary for the Society for Risk Analysis (SRA) and has held leadership roles in specialty sections of SRA and SOT. He is currently on the editorial board of two journals. Dr. Dourson has published more than 100 papers on risk assessment methods, has co-authored over 100 government risk assessment documents, and has made over 100 invited presentations.